Lannebo Fonder Ab Omnicell, Inc Transaction History

Lannebo Fonder Ab

$758 Million
Q4 2023

A detailed history of Lannebo Fonder Ab transactions in Omnicell, Inc stock. As of the latest transaction made, Lannebo Fonder Ab holds 28,000 shares of OMCL stock, worth $1.26 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

28,000

Previous 28,000 -0.0%

Holding current value

$1.26 Million

Previous $1.28 Million 16.12%

% of portfolio

0.14%

Previous 0.19%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	BUY	$46.24 - $90.03 $184,960 - $360,120	4,000 Added 16.67%	28,000 $1.41 Million
Q3 2022 Oct 20, 2022	BUY	$84.23 - $117.38 $84,230 - $117,380	1,000 Added 4.35%	24,000 $2.09 Million
Q2 2022 Jul 15, 2022	BUY	$105.64 - $129.11 $316,920 - $387,330	3,000 Added 15.0%	23,000 $2.62 Million
Q4 2021 Jan 27, 2022	SELL	$153.26 - $183.62 $851,359 - $1.02 Million	-5,555 Reduced 21.74%	20,000 $3.61 Million
Q2 2021 Jul 20, 2021	BUY	$129.91 - $151.45 $202,010 - $235,504	1,555 Added 6.48%	25,555 $3.87 Million
Q1 2021 Apr 29, 2021	SELL	$117.78 - $143.9 $58,890 - $71,950	-500 Reduced 2.04%	24,000 $3.12 Million
Q4 2020 Feb 04, 2021	SELL	$73.85 - $120.02 $295,400 - $480,080	-4,000 Reduced 14.04%	24,500 $2.94 Million
Q3 2020 Oct 30, 2020	BUY	$63.15 - $77.12 $720,667 - $880,093	11,412 Added 66.78%	28,500 $2.13 Million
Q2 2020 Aug 10, 2020	BUY	$59.36 - $74.43 $337,639 - $423,357	5,688 Added 49.89%	17,088 $1.21 Million
Q1 2020 May 11, 2020	BUY	$55.41 - $90.19 $315,837 - $514,083	5,700 Added 100.0%	11,400 $748,000
Q4 2019 Feb 18, 2020	BUY	$70.15 - $83.11 $399,855 - $473,727	5,700 New	5,700 $466,000

Others Institutions Holding OMCL

# of Institutions

277

Shares Held

44.6M

Call Options Held

224K

Put Options Held

35.7K

View Full List

About OMNICELL, Inc

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $2B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

More about OMCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lannebo Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Lannebo Fonder Ab with notifications on news.

Account

Lannebo Fonder Ab Omnicell, Inc Transaction History